Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2022 ∙ Omolaoye, T. S. Velilla, P. A. Moncada López, J. S. du Plessis, S. S. Cardona Maya, W. D.

SARS-CoV-2 Vaccine Effects on Semen Parameters: A Systematic Review and Meta-Analysis

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Ippolito, S. Gallo, D. Rossini, A. Patera, B. Lanzo, N. Fazzino, G. F. M. Piantanida, E. Tanda, M. L.

SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Avallone, G. Quaglino, P. Cavallo, F. Roccuzzo, G. Ribero, S. Zalaudek, I. Conforti, C.

SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ De Rose, D. U. Salvatori, G. Dotta, A. Auriti, C.

SARS-CoV-2 Vaccines during Pregnancy and Breastfeeding: A Systematic Review of Maternal and Neonatal Outcomes

  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Yin, J. Chen, Y. Li, Y. Zhang, X. Wang, C.

Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Verleye, A. Wijtvliet, V. Abrams, S. Hellemans, R. Bougrea, R. Massart, A. Pipeleers, L. Wissing, K. M. Ariën, K. K. De Winter, B. Y. Van Damme, P. Abramowicz, D. Ledeganck, K. J.

Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis

  • Adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Corti, C. Antonarelli, G. Scotté, F. Spano, J. P. Barrière, J. Michot, J. M. André, F. Curigliano, G.

Seroconversion rate after vaccination against COVID-19 in patients with cancer - a systematic review

  • All age groups
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Ge, C. Du, K. Luo, M. Shen, K. Zhou, Y. Guo, K. Liu, Y. Yin, C. Li, Y. Li, G. Chen, X.

Serologic response and safety of COVID-19 vaccination in HSCT or CAR T-cell recipients: a systematic review and meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Sakuraba, A. Luna, A. Micic, D.

Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Chen, D. Pan, Y. Wang, Y. Chen, X. Zhang, J. Zhang, Y. Ding, T. Yang, Z. Lu, T. Zheng, Y. Wei, J. Kong, W. Li, H. Yin, X. Yang, G. Zhang, G. Wang, X.

Serological response to COVID-19 vaccine and its predictors in patients with solid malignancies: a systematic review and meta-analysis of 16 cohort studies

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...